Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Minority Interest (2020 - 2025)

Historic Minority Interest for Privia Health (PRVA) over the last 6 years, with Q3 2025 value amounting to $53.6 million.

  • Privia Health's Minority Interest rose 1340.71% to $53.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.6 million, marking a year-over-year increase of 1340.71%. This contributed to the annual value of $48.3 million for FY2024, which is 503.13% up from last year.
  • According to the latest figures from Q3 2025, Privia Health's Minority Interest is $53.6 million, which was up 1340.71% from $50.7 million recorded in Q2 2025.
  • Privia Health's 5-year Minority Interest high stood at $53.6 million for Q3 2025, and its period low was -$5.6 million during Q3 2021.
  • Moreover, its 5-year median value for Minority Interest was $46.0 million (2023), whereas its average is $32.8 million.
  • Examining YoY changes over the last 5 years, Privia Health's Minority Interest showed a top increase of 89419.74% in 2022 and a maximum decrease of 1438.93% in 2022.
  • Over the past 5 years, Privia Health's Minority Interest (Quarter) stood at $23.3 million in 2021, then decreased by 14.39% to $20.0 million in 2022, then soared by 130.28% to $46.0 million in 2023, then rose by 5.03% to $48.3 million in 2024, then increased by 11.13% to $53.6 million in 2025.
  • Its Minority Interest was $53.6 million in Q3 2025, compared to $50.7 million in Q2 2025 and $50.1 million in Q1 2025.